NuGene International, Inc. filed its 10-12G on Jul 11, 2022 for the period ending Dec 31, 2021. In this report its auditor, Olayinka Oyebola & Co, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.017 USD | -2.86% | +23.19% | +42.86% |
06/05 | Livento Group, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
01/04 | Livento Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+42.86% | 14.13M | |
+12.81% | 8.1B | |
-1.87% | 6.39B | |
+3.19% | 5.3B | |
+1.36% | 4.41B | |
+9.47% | 4.32B | |
+12.02% | 3.67B | |
+19.65% | 3.14B | |
-6.21% | 2.96B | |
-9.91% | 2.51B |
- Stock Market
- Equities
- NUGN Stock
- News Livento Group, Inc.
- NuGene International, Inc. Auditor Raises 'Going Concern' Doubt